Search Orphan Drug Designations and Approvals
-
Generic Name: | Human Insulin (rDNA) |
---|---|
Date Designated: | 02/28/2022 |
Orphan Designation: | Prevention of Retinopathy of Prematurity (ROP) |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Elgan Pharma, Ltd. Wadi El Haj 13 Nazareth, Israel 16100 Israel The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-